Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.852
Abstract: Letermovir is a prophylactic agent for cytomegalovirus infection and disease in adult cytomegalovirus‐seropositive recipients of allogeneic hematopoietic stem cell transplant. As the antifungal agent fluconazole is administered frequently in transplant recipients, a drug–drug interaction study…
read more here.
Keywords:
pharmacokinetic interaction;
interaction letermovir;
assessment pharmacokinetic;
coadministration fluconazole ... See more keywords